Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06569693 · ClinicalTrials.gov registry record · NA

Dyadic Sleep Study

A NA study of Gastrointestinal Cancer, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
152
Enrollment target
2
Study locations

NCT06569693 is a NA study of Gastrointestinal Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 152 participants, below the 231-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (34% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06569693, a NA study of Gastrointestinal Cancer, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
152 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and caregiver partners.

Conditions Studied

Interventions

  • BEHAVIORAL Brief Behavioral Treatment for Insomnia (BBTI)
  • BEHAVIORAL My Sleep Our Sleep (MSOS) Program

Study Locations (2)

Florida

  • University of Miami - Coral Gables

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2024-10-22
Est. Completion 2026-12-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06569693

The ClinicalTrials.gov registry entry for NCT06569693 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (34% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Brief Behavioral Treatment for Insomnia (BBTI) is the first listed.

NCT06569693 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06569693 about?

NCT06569693 is a clinical study titled "Dyadic Sleep Study". The purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and caregiver partners.

What is the current status of trial NCT06569693?

This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2024-10-22. Estimated completion is 2026-12-01.

What conditions does trial NCT06569693 study?

This clinical trial studies the following conditions: Gastrointestinal Cancer.

What interventions are being tested in trial NCT06569693?

The interventions under investigation include: Brief Behavioral Treatment for Insomnia (BBTI) (BEHAVIORAL), My Sleep Our Sleep (MSOS) Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06569693?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06569693 being conducted?

This trial has 2 study locations across Florida, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.